OTC: Cough and Cold

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/26

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

27 Terms

1
New cards

Common Cold Etiology

Common “Virus”

Rhinovirus common agent

2
New cards

Common Cold Transmission

  • Self-inoculation with viral-laden secretions

  • aerosol transmission

increased risk of transmission if:

  • smoking

  • high pop density

  • sedentary lifestyle

  • chronic stress

3
New cards

Common Cold Progression

  • 1-3 days

    • sore throat, sneezing

    • low-grade fever (100ºF) ((may be viral))

  • 2-3 days → most infectious

    • rhinorrhea

    • peak symptoms

    • peak viral concentration (most infectious)

  • 4-5 days

    • residual cough late-stage

Symptoms last about: 7-14 days

4
New cards

Differentiating Factors…

  1. Common Cold: slow onset

  2. Allergic Rhinitis: bilateral, watery/itchy eyes

  3. Asthma: wheezing

  4. Bacterial Throat Infection: exudate

  5. Influenza: sudden onset, fatigue

  6. Sinusitis: fever over 101.5ºF indicative of bacterial infection

  7. COVID-19: fever, fatigue, loss of taste/smell

5
New cards

Nonpharm Approaches to Cold

  1. limit transmission

  2. wash hands

  3. hand sanitizers

  4. increased fluid intake

  5. rest

  6. chicken noodle soup

  7. increased humidification

6
New cards

Cold: Exclusions to Self-Treatment

  • Fever >100.4ºF (may be bacterial)

  • chest pain

  • shortness of breath

  • COPD, asthma, coronary heart failure

  • immunocompromised

  • frail

  • infants < 3 months of age

  • symptoms no improve 7-14 days

7
New cards

Single vs Combo Products

Single entity products → preferred

  • treats appropriate symptoms only

  • better dosing accuracy

Combo products → ease of use (cheaper)

  • unnecessary products for no symptoms

8
New cards

Decongestants

Indication: sinus and nasal congestion

Sympathomimetics: alpha-AR agonists

  • vasoconstriction, adrenaline effects

  • clears sinuses

ADR: cardiovascular + CNS stimulation

hypertension, tachycardia, anxiety, tremors, insomnia

9
New cards

Decongestant Pre-cautions

  • Do NOT use with MAOI’s

  • Do NOT use if patient has uncontrolled:

    • hypertension

    • hyperthyroidism

    • diabetes

    • coronary heart disease

  • Do NOT use with Tricyclic Antidepressants

    • increased cardiovascular toxicity

10
New cards

Pseudoephedrine

decongestant of choice

  • q4-6 hours in 24 hours

2 - 6 years → 15 mg

6 - 12 years → 30 mg

>12 years → 60 mg

11
New cards

CMEA 2005

Combat Methamphetamine Epidemic Act

  • logs patient name, address, point of sale

SALE LIMITS:

no more than 3.6 g per day (3600 mg/day)

no more than 9 g per 30 days (9000 mg/30day)

no more than 7.5 g per mail order

#30 count bottle x sudafed mg = how much in 30 days

9000 - x = mg left can buy/other sudafed mg strength

12
New cards

Topical Decongestants (nasal)

Oxymetazoline (Afrin)

  • > 6 years old

  • 2-3 sprays q10-12 hours

Phenylephrine 0.5% - 1%

  • >12 years

  • 2-3 sprays q4 hours

Phenylephrine 0.125%

  • 2 - 6 years old

  • 2-3 sprays q4h

chronic use = rebound contestant

do not use more than 3-5 days

can be used for both cold and allergies*

13
New cards

Antihistamines for Cold

→ First generation only effective in cold

  • anticholinergic effects relieves inflammatory responses

  • sedation for sleeping while sick

  • antitussive effects

  • beneficial for patients with heart problems who cannot take psuedofed

chlorophenamine, diphenhydramine

→ Second generation not for cold use

14
New cards

Local Anesthetics (Analgesia)

Demulcents and Anesthetics Local Action

  • Demulcents; cover mucus throat membrane

    • cough drops

  • Anesthetics; inhibit pain proprioception

    • Benzocaine

    • Menthol

    • Phenol Spray (good for children)

15
New cards

Systemic Analgesics

ASA, APAP, and NSAIDs

  • treat swelling of sinus cavity, headache, aches, fevers, throat pain

16
New cards

Cough Classifications

  1. Acute < 3 weeks

    1. treatable with OTC

    2. viral agent causation

  2. Subacute 3 - 8 weeks

  3. Chronic > 8 weeks

17
New cards

Wet Cough vs Dry Cough

Wet Cough: productive cough

  • expels secretions and mucus from lower respiratory tract

  • bacterial infections, bronchitis

Dry Cough: nonproductive cough

  • hacking, no physiological purpose

  • viral infections, GERD, meds

18
New cards

Exlcusions to Cough Self-Care

  • Children < 4 years of age

  • Thick yellow sputum/green phlegm

    • may be bacterial causative agent

  • Productive cough (?)

  • Fever

  • Shortness of breath

  • unintended weight loss

  • night time sweats

  • chest pain

  • persistent headache

  • swelling in legs/ankles

  • underlying conditions: asthma, COPD, chronic bronchitis, coronary heart failure

  • drug induced cough

  • lasting > 7 days

19
New cards

Differentiation Factors: Cough

  1. Asthma: wheezing, cough at night

  2. CHF: Edema

  3. COPD: productive cough

  4. GERD: heartburn, worse when laying down

  5. Lower Resp. Infection: fever, discolored phlegm

  6. Allergies: runny nose

  7. Viral URTI: sneezing, runny nose

20
New cards

Honey Therapy for Cough

5-10 mL PO before bedtime

→ DO NOT use honey if < 1 year old

  • risk of botulism

2-5 years: ½ teaspoon

6-11: 1 teaspoon

12-18: 2 teaspoons

21
New cards

Antitussives

MOA: increases cough threshold

  • Codeine

  • Dextromethorphan

  • Diphenhydramine

  • Chlophedianol

  • Topical for throat (menthol, camphor)

22
New cards

Codeine

First Line Antitussive for Cough

weak opiate agonist for 18 years and older

→ converted to morphine by CYP2D6

increases cough threshold

dries out resp. mucosa

dosing: max 200 mg/100 mL

60 mg/dose, 360 mg/day

SE opiate associated: constipation, dependence, respi. depression, hypotension

23
New cards

Codeine Drug Interactions

  • CNS depressants

  • 2D6 inducers/inhibiitors

    • antiarrhythmics, SSRIs, H2RA

24
New cards

Dextromethorphan

Second Line Antitussive for Cough

Robitussin

→ increases cough threshold (non-opiate) via antagonism of NMDA receptors

  • abuse potential

  • limited efficacy

10-20 mg q4 hours, max 120 mg/day

DIs: MAOIs, antidepressants, antipsychotics, 2D6/3A4 substrates

25
New cards

Diphenhydramine

First Generation Sedating Antihistamine

→ may be used as antitussive

least effective, but may dry out post-nasal drip

26
New cards

Guaifenesin

Protussive/Expectorant

Mucinex

MOA: increases hydration of resp. tract and reduces mucus viscosity

→ indicated for acute productive coughs with thick secretions

  • 200-400 mg q4 hours

may be used in the elderly as a substitution for inadequate water drinking/hydration

27
New cards

bottom line advice for cough

cough caused by post-nasal drip

  • 1st generation antihistamine + decongestant

cough interfering with sleep/work

  • codeine or dextromethaphan